Abstract
The design and synthesis of 4-alkynyl pyrazole derivatives has led to the identification of new class of PDE4 inhibitors. All these compounds were accessed for the first time via a facile Pd/C-CuI-PPh(3) mediated C-C bond forming reaction between an appropriate pyrazole iodide and various terminal alkynes. In vitro PDE4B inhibitory properties and molecular modeling studies of some of the compounds synthesized indicated that 4-alkynyl pyrazole could be a promising template for the discovery of novel PDE4 inhibitors.
Copyright © 2012 Elsevier Ltd. All rights reserved.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Alkynes / chemistry*
-
Alkynes / pharmacology
-
Antidepressive Agents / chemical synthesis
-
Antidepressive Agents / pharmacology
-
Catalysis
-
Computer Simulation
-
Copper / chemistry
-
Cyclic Nucleotide Phosphodiesterases, Type 4 / chemistry*
-
Dose-Response Relationship, Drug
-
Drug Design
-
Humans
-
Iodides / chemistry
-
Models, Molecular
-
Palladium / chemistry
-
Phosphodiesterase 4 Inhibitors / chemical synthesis*
-
Phosphodiesterase 4 Inhibitors / pharmacology
-
Pyrazoles / chemical synthesis*
-
Pyrazoles / pharmacology
-
Rolipram / pharmacology
Substances
-
Alkynes
-
Antidepressive Agents
-
Iodides
-
Phosphodiesterase 4 Inhibitors
-
Pyrazoles
-
Palladium
-
Copper
-
Cyclic Nucleotide Phosphodiesterases, Type 4
-
Rolipram